Enhance #medicalimaging solutions with NVIDIA VISTA-3D NIM microservice. Experience fast, accurate segmentation across 127 anatomical structures and various lesions. #healthcare nvda.ws/3Ys3Zdo

Now available – Diffdock NIM This #NVIDIANIM achieves scalable molecular docking with 7x faster pose predictions, reducing costs in virtual screening and lead optimization. Get started today. #drugdiscovery nvda.ws/4ceSTM5

Now available – Molmim NIM This #NVIDIANIM optimizes and samples molecules efficiently in virtual screening and lead optimization for faster, more effective results. Get started today. #drugdiscovery nvda.ws/4duzMPr

.Writer’s new domain-specific #LLMs, Palmyra-Med-70b and Palmyra-Fin-70b, help #healthcare and financial industries to build #genAI applications infused with industry knowledge and expertise. Get started with these new NVIDIA #NIM microservices. nvda.ws/4fAIihs

Tune in to hear Chris Gibson, cofounder and CEO of Recursion, discuss how #AI is transforming the biopharmaceutical industry by increasing efficiency and lowering discovery costs. #drugdiscovery #healthcare nvda.ws/3SHcyh0

Meet James, an interactive digital human knowledgeable about our products. Talk to James ➡️ nvda.ws/3Wxzosu 💬 James uses a collection of NVIDIA and ElevenLabs digital human technologies to provide natural and immersive responses.

Scale up your research with the #100MillionCellChallenge! 📈 First 50M cells accepted highly subsidized. Early submissions get priority review. Submit your 1M+ cell project now! hubs.la/Q02Lc1ps0 #QuantumScale #SingleCell

Get the latest in AI-powered #healthcare directly to your inbox! Be the first to know the latest #AI in healthcare news, success stories, and tech tips. Join us in transforming healthcare! nvda.ws/3WNFQf2

To give the best care, cancer researchers at the Wellcome Sanger Institute are using #acceleratedcomputing solutions. Learn more about how NVIDIA technologies are making it possible to reduce analysis runtime and energy consumption. #healthcare #Parabricks nvda.ws/3WTfqc0

NVentures backed Terray Therapeutics, has unveiled COATI-LDM—a groundbreaking #genAI model for designing small molecules with precision. This innovative example of inverse design has potential to greatly accelerate #drugdiscovery. Check out the arXiv preprint nvda.ws/3MhwqDF

Announcing the generative virtual screening for drug discovery NIM Agent Blueprint, a paradigm shift to the #drugdiscovery process to help researchers identify and develop drug candidates faster and with fewer steps. #NIM #GenerativeAI nvda.ws/3X3Cbdb

Announcing NVIDIA NIM Agent Blueprints, reference applications for every enterprise to make their own #AI. They equip developers with apps for building generative AI use cases such as digital humans, PDF data extraction, and virtual screening. nvda.ws/3X2RenB

Now available — AlphaFold2 NIM. Groundbreaking #AI for protein structure prediction. This #NVIDIANIM is set to revolutionize #drugdiscovery and molecular #biology—bringing secure, reliable deployment to scientists everywhere. #healthcare nvda.ws/3X5QmOS

Accelerate the virtual screening of small molecules using generative models. Try our newly released generative virtual screening for #drugdiscovery NIM Agent Blueprint, consisting of three #AI #NIM microservices AlphaFold2, Diffdock and MolMIM. nvda.ws/4fYES8p

NVIDIA NIM optimizes #generativeAI in #RAG applications, streamlining #LLM integration and management, and enhancing #AI-generated responses through NVIDIA reranking #NIM microservice models. Check out the technical blog for details. nvda.ws/3MwrkUo

🚀 SOPHiA GENETICS launches the New Generation SOPHiA DDM™ Platform! Our new-gen platform integrates the latest advancements in data processing and technology, offering our customers an elevated experience & enhanced capabilities. Read our #PressRelease: loom.ly/VmhfcIw